The representative body of the US Biotechnology industry, BIO, has joined PhRMA in criticising President Donald Trump's executive order directing administration officials to secure the 'Most Favored Nation' pharmaceutical pricing.
US BIO joins PhRMA in challenging Trump over 'Most Favored Nation' order
May 14, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
CSL Behring wins major international pharmaceutical engineering award
May 14, 2025 - - Latest News -
Lumos advances FebriDx sales with iMedical purchase order
May 14, 2025 - - Australian Biotech -
US BIO joins PhRMA in challenging Trump over 'Most Favored Nation' order
May 14, 2025 - - Latest News -
Mark Butler tasked with delivering PBS-level reduction in NDIS spending
May 14, 2025 - - Latest News -
New Liberal leader Sussan Ley was responsible for major PBS reforms
May 13, 2025 - - Latest News -
New administrative order confirms the total move of NDIS to health
May 13, 2025 - - Latest News -
Trump's language on pricing matches Australia's reflex response to PBS criticism
May 13, 2025 - - Latest News